← Leaderboards
Paul John Norman
University Of Colorado Denver
$13,162,878
Attributed
$14,303,622
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,303,622 · 8
By mechanism
R01$9,058,902 · 4
U01$4,279,361 · 1
R56$747,496 · 2
R21$217,863 · 1
Top collaborators
- Jill Allison Hollenbach3 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Frank J. Accurso$3,381,974
- Laurent Gapin$8,662,236
Others in their field
Other Emerging Leaders on “Killer Cells”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Wilton B Williams · Duke University$11,648,165
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$10,801,454
- Deanna A Kulpa · Emory University$8,444,989
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$7,776,394
- Emily Margaret Mace · Columbia University Health Sciences$6,560,188
Research focus
Killer CellsReceptorNatural Killer CellsAllelesImmunoglobulinsVariantResolutionCell PhysiologyPredispositionMediatingGenotypeCellsResponseImmunityGenesGenetic VariationSpecificityGenetic PolymorphismImmune ResponseGeneticComplexCohortHla AntigensCountry
Grant awards (21)
Integrating genomic architecture and tuberculosis (TB) immunity in Africa$802,499
R01 · FY2025 · AI · contact PI
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere$767,423
R01 · FY2025 · AI · contact PI
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course$753,576
R01 · FY2025 · AI
Insights Into Immune-Related Diseases Born from Population Genomics$633,308
U01 · FY2025 · AI · contact PI
Comparing NK cell profiles within melanoma tumors and pregnancy: Implications for novel immunotherapies$217,863
R21 · FY2025 · CA · contact PI
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere$767,423
R01 · FY2024 · AI · contact PI
Insights Into Immune-Related Diseases Born from Population Genomics$719,776
U01 · FY2024 · AI · contact PI
Natural Killer cells and the Immunogenetics of COVID-19$706,411
R01 · FY2024 · AI · contact PI
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere$766,987
R01 · FY2023 · AI · contact PI
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course$760,808
R01 · FY2023 · AI
Insights Into Immune-Related Diseases Born from Population Genomics$719,950
U01 · FY2023 · AI · contact PI
Natural Killer cells and the Immunogenetics of COVID-19$714,601
R01 · FY2023 · AI · contact PI
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere$794,519
R01 · FY2022 · AI · contact PI
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course$767,105
R01 · FY2022 · AI
Insights Into Immune-Related Diseases Born from Population Genomics$719,950
U01 · FY2022 · AI · contact PI
Natural Killer cells and the Immunogenetics of COVID-19$714,785
R01 · FY2022 · AI · contact PI
Natural Killer cells and the Immunogenetics of COVID-19$742,765
R01 · FY2021 · AI · contact PI
Insights Into Immune-Related Diseases Born from Population Genomics$720,399
U01 · FY2021 · AI · contact PI
Control of Cytotoxic Lymphocytes by Polymorphic KIR3DL3$360,030
R56 · FY2021 · AI · contact PI
Insights Into Immune-Related Diseases Born from Population Genomics$765,978
U01 · FY2020 · AI · contact PI
Evolution and Function of Immunogenetic Diversity Across the Eastern Hemisphere$387,466
R56 · FY2020 · AI · contact PI